Atlas Trials

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

Clinical trial NCT00023348 · COMPLETED

Trial details

NCT number
NCT00023348
Sponsor
Centers for Disease Control and Prevention
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HIV InfectionsTuberculosis
Start date
1999-07-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.